Skip Navigation



Cardiovascular Research Advance Access [Accepted Manuscript] published online on October 26, 2007

Cardiovascular Research, doi:10.1093/cvr/cvm051
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
77/1/35    most recent
cvm051v2
cvm051v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Voigt, N.
Right arrow Articles by Nattel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voigt, N.
Right arrow Articles by Nattel, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Changes in IK,ACh single channel activity with atrial tachycardia remodeling in canine atrial cardiomyocytes

Niels Voigt, Ange Maguy, Yung-Hsin Yeh, Xiaoyan Qi, Ursula Ravens, Dobromir Dobrev and Stanley Nattel

Department of Pharmacology and Toxicology, Dresden University of Technology, Germany(N.V., U.R., D.D.) and Research Center, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada (N.V., A.M., Y.Y., X.Q.,S.N.)

Address for correspondence: Stanley Nattel, Research Center, Montreal Heart Institute, 5000 Belanger Street E, Montreal, Quebec, H1T 1C8, Canada E-mail: stanley.nattel{at}icm-mhi.org

Changes in IK,ACh single channel activity with atrial tachycardia remodeling in canine atrial cardiomyocytes. Niels Voigt, Ange Maguy, Yung-Hsin Yeh, Xiaoyan Qi, Ursula Ravens, Dobromir Dobrev, Stanley Nattel

Aims: Although atrial tachycardia (AT) remodeling promotes agonist-independent, constitutively active, acetylcholine-regulated K+ current (IK,ACh) that increases susceptibility to atrial fibrillation (AF), the underlying changes in IK,Ach channel function are unknown. This study aimed to establish how AT remodeling affects IK,ACh single channel function.

Methods: IK,ACh single channel activity was studied via cell-attached patch-clamp in isolated left atrial cardiomyocytes of control and AT (7 days, 400 min–1) dogs.

Results: AT prolonged the mean duration of induced AF from 44±22 to 413±167 s and reduced atrial effective refractory period at a 360 ms cycle length from 126±3 to 74±5 ms (n=9/group p<0.001). In the absence of cholinergic stimulation, single channel openings with typical IK,ACh conductance and rectification properties were sparse under control conditions. AT induced prominent agonist-independent IK,ACh activity due to increased opening frequency (fo) and open probability (Po: ~7- and ~10-fold respectively versus control), but did not alter open time constant, single channel conductance and membrane density. With maximum IK,ACh activation (10 µmol/L carbachol), channel Po was enhanced much more in control cells (~42 fold) than in AT-remodeled myocytes (~5-fold). The selective Kir3 current blocker tertiapin (100 nmol/L) reduced fo and Po at -100 mV by 48% and 51%, respectively (p<0.05 for each), without altering other channel properties, confirming the identity of IK,ACh. AT had no significant effect on mRNA or protein expression of either of the subunits (Kir3.1, Kir3.4) underlying IK,ACh.

Conclusions: AT increases agonist-independent constitutive IK,ACh single channel activity by enhancing spontaneous channel opening, providing a molecular basis for AT effects on macroscopic IK,ACh observed in previous studies, as well as associated refractoriness abbreviation and tertiapin-suppressible AF promotion. These results suggest an important role for constitutive IK,Ach channel opening in AT remodeling and support its interest as a potential target for AF therapy.

KEYWORDS acetylcholine; antiarrhythmic agents; arrhythmia (mechanisms); ion channels; remodeling


Time for primary review: 10 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EuropaceHome page
I. Savelieva and J. Camm
Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches
Europace, June 1, 2008; 10(6): 647 - 665.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythmia ElectrophysiolHome page
S. Nattel, B. Burstein, and D. Dobrev
Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications
Circ Arrhythmia Electrophysiol, April 1, 2008; 1(1): 62 - 73.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.